N/A N=40 Randomized Triple-blind Treatment

Beneficial Effects of Magnesium Supplementation On Idiopathic Muscle Cramps

Muscle Cramp

Bottom Line

View on ClinicalTrials.gov: NCT00963638 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2011

Primary outcome: Primary: Change in Frequency of Leg Cramps — .99; .53 Cramps per week

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: MagTabSR (Dietary_supplement); Placebo (Dietary_supplement)
Age: Adult, Older Adult · 40+ yrs
Sex: All
Sponsor: Corewell Health East
Primary completion: Nov 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Frequency of Leg Cramps	.99; .53	—
PRIMARY Frequency/Duration of Muscle Cramps	—	—

Summary

The goal of this study is to evaluate the effectiveness of magnesium supplements (MagTabSR 168 mgs twice daily) for relief and/or improvement in the frequency, duration, and intensity of chronic leg cramps. Improvement in sleep disturbances and quality of life will also be evaluated.

Eligibility Criteria

Inclusion Criteria

40-85 Years Old
No Kidney Impairment
2 or more leg cramps per week for last 30 days

Exclusion Criteria

85 Years Old
Kidney Impairment
< 2 leg cramps per week for last 30 days
Enrolled in another research study
History of seizure disorder
Current treatment with Lithium
Malabsorption or major intestinal disorders
Significantly elevated magnesium level
History of allergy to magnesium compound
Use of Quinine for leg cramps
History of significant diarrhea
History of drug or alcohol abuse in the last 2 years
Currently diagnosed with a terminal illness

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00963638). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.